Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Anlon Healthcare Limited
Meeting Details
- Date: Saturday, September 5, 2026
- Time: 11:00 a.m. IST
- Location: Conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
- Deemed Venue: Registered Office at 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat
Proposed Resolutions and Implications
Ordinary Business:
1. Item 1: Adoption of audited standalone financial statements for FY2025-26 with reports of Board of Directors and Auditors
2. Item 2: Adoption of audited consolidated financial statements for FY2025-26 with reports of Board of Directors and Auditors
3. Item 3: Re-appointment of Mr. Punitkumar Rameshbhai Rasadia (DIN: 06696258) who retires by rotation
Special Business:
4. Item 4: Appointment of Mr. Kishan Vinodkumar Raja (DIN: 11522235) as Non-Executive & Independent Director for five years commencing February 9, 2026
5. Item 5: Approval of remuneration of ₹45,000 plus expenses plus applicable taxes to M/s M. C. Bambhroliya & Associates as Cost Auditor for FY2026-27
6. Item 6: Enhancement of authorized share capital from ₹110 crore (55 crore equity shares of ₹2 each) to ₹130 crore (65 crore equity shares of ₹2 each)
7. Item 7: Alteration of Capital Clause in Memorandum of Association to reflect increased authorized capital
8. Item 8: Major Acquisition - Issuance of 8,58,83,617 equity shares on preferential basis for consideration other than cash to shareholders of Apiqo Organics Private Limited and Bizotic Lifescience Private Limited:
- Acquisition of 44.94% stake in Apiqo Organics (45,16,200 shares) for ₹116.52 crore via issuance of 6,52,76,283 shares at ₹17.85 per share
- Acquisition of 47.41% stake in Bizotic Lifescience (22,99,000 shares) for ₹36.78 crore via issuance of 2,06,07,334 shares at ₹17.85 per share
- Total consideration: ₹153.30 crore
- Floor price determined as per SEBI ICDR Regulations with valuation by CA Gaurang Agarwal dated August 6, 2026
- Complete list of 171 allottees with detailed share allocation provided in tables
9. Item 9: Material related party transactions with Apiqo Organics Private Limited aggregating up to ₹80 crore for FY2026-27
10. Item 10: Material related party transactions with Bizotic Lifescience Private Limited aggregating up to ₹60 crore for FY2026-27
11. Item 11: Material related party transactions with Anlon Medicos Private Limited aggregating up to ₹50 crore for FY2026-27
Voting Process and Methods
- Remote e-Voting Period: September 2, 2026 (9:00 AM) to September 4, 2026 (5:00 PM)
- Voting during AGM: e-voting facility available during meeting for those who haven't voted remotely
- Cut-off Date: August 28, 2026 for determining voting rights
- Scrutinizer: M/s K.P. Ghelani & Associates, Company Secretaries appointed to scrutinize voting process
- Registration of Members: Members must register email addresses with Depository Participants/Company for electronic communication
Key Voting Information
- Register Closure: August 29, 2026 to September 4, 2026 (both days inclusive)
- Voting Rights: Proportional to shareholding as on cut-off date
- Participation Limit: 1,000 members on first-come-first-served basis (excludes large shareholders, promoters, institutions, directors, KMPs, committee chairpersons, auditors)
- Proxy Facility: Not available for VC/OAVM meeting
Compliance with Laws and Regulations
The notice confirms compliance with:
- Companies Act, 2013 and rules thereunder
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI Circulars regarding e-voting and virtual meetings
- Secretarial Standards issued by ICSI
- MCA Circulars permitting virtual AGMs
Additional Information
- The AGM notice and annual report have been sent electronically to members with registered email addresses
- Documents available on company website www.anlon.in and stock exchange websites
- Members can submit questions in advance by August 28, 2026 to cs@anloncro.com
- Share registry services handled by KFin Technologies Limited
- Permanent Account Number (PAN) submission mandatory for all participants as per SEBI guidelines
- Detailed instructions provided for remote e-voting through NSDL and CDSL systems
- The preferential issue is subject to receipt of necessary regulatory approvals and in-principle listing approval from stock exchanges